Using the Translating Research into Practice framework to develop a diabetes prevention intervention in primary care: a mixed-methods study.

IF 1.3 Q4 HEALTH CARE SCIENCES & SERVICES
Eva Tseng, Katherine Smith, Jeanne M Clark, Jodi B Segal, Jill A Marsteller, Nisa M Maruthur
{"title":"Using the Translating Research into Practice framework to develop a diabetes prevention intervention in primary care: a mixed-methods study.","authors":"Eva Tseng, Katherine Smith, Jeanne M Clark, Jodi B Segal, Jill A Marsteller, Nisa M Maruthur","doi":"10.1136/bmjoq-2024-002752","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pre-diabetes affects one-third of US adults and increases the risk of type 2 diabetes. Effective evidence-based interventions, such as the Diabetes Prevention Program, are available, but a gap remains in effectively translating and increasing uptake of these interventions into routine care.</p><p><strong>Methods: </strong>We applied the Translating Research into Practice (TRiP) framework to guide three phases of intervention design and development for diabetes prevention: (1) summarise the evidence, (2) identify local barriers to implementation and (3) measure performance. In phase 1, we conducted a retrospective cohort analysis of linked electronic health record claims data to evaluate current practices in the management of pre-diabetes. In phase 2, we conducted in-depth interviews of 16 primary care physicians, 7 payor leaders and 31 patients to elicit common barriers and facilitators for diabetes prevention. In phase 3, using findings from phases 1 and 2, we developed the core elements of the intervention and performance measures to evaluate intervention uptake.</p><p><strong>Results: </strong>In phase 1 (retrospective cohort analysis), we found few patients with pre-diabetes received diabetes prevention interventions. In phase 2 (stakeholder engagement), we identified common barriers to include a lack of knowledge about pre-diabetes among patients and about the Diabetes Prevention Program among clinicians. In phase 3 (intervention development), we developed the START Diabetes Prevention Clinical Pathway as a systematic change package to address barriers and facilitators identified in phases 1 and 2, performance measures and a toolkit of resources to support the intervention components.</p><p><strong>Conclusions: </strong>The TRiP framework supported the identification of evidence-based care practices for pre-diabetes and the development of a well-fitted, actionable intervention and implementation plan designed to increase treatment uptake for pre-diabetes in primary care settings. Our change package can be adapted and used by other health systems or clinics to target prevention of diabetes or other related chronic conditions.</p>","PeriodicalId":9052,"journal":{"name":"BMJ Open Quality","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163602/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Quality","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjoq-2024-002752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pre-diabetes affects one-third of US adults and increases the risk of type 2 diabetes. Effective evidence-based interventions, such as the Diabetes Prevention Program, are available, but a gap remains in effectively translating and increasing uptake of these interventions into routine care.

Methods: We applied the Translating Research into Practice (TRiP) framework to guide three phases of intervention design and development for diabetes prevention: (1) summarise the evidence, (2) identify local barriers to implementation and (3) measure performance. In phase 1, we conducted a retrospective cohort analysis of linked electronic health record claims data to evaluate current practices in the management of pre-diabetes. In phase 2, we conducted in-depth interviews of 16 primary care physicians, 7 payor leaders and 31 patients to elicit common barriers and facilitators for diabetes prevention. In phase 3, using findings from phases 1 and 2, we developed the core elements of the intervention and performance measures to evaluate intervention uptake.

Results: In phase 1 (retrospective cohort analysis), we found few patients with pre-diabetes received diabetes prevention interventions. In phase 2 (stakeholder engagement), we identified common barriers to include a lack of knowledge about pre-diabetes among patients and about the Diabetes Prevention Program among clinicians. In phase 3 (intervention development), we developed the START Diabetes Prevention Clinical Pathway as a systematic change package to address barriers and facilitators identified in phases 1 and 2, performance measures and a toolkit of resources to support the intervention components.

Conclusions: The TRiP framework supported the identification of evidence-based care practices for pre-diabetes and the development of a well-fitted, actionable intervention and implementation plan designed to increase treatment uptake for pre-diabetes in primary care settings. Our change package can be adapted and used by other health systems or clinics to target prevention of diabetes or other related chronic conditions.

利用 "将研究转化为实践 "框架在初级保健中制定糖尿病预防干预措施:一项混合方法研究。
背景:三分之一的美国成年人患有糖尿病前期,这增加了罹患 2 型糖尿病的风险。目前已有有效的循证干预措施,如糖尿病预防计划,但在将这些干预措施有效转化为常规护理并提高其使用率方面仍存在差距:我们采用了 "将研究转化为实践"(TRiP)框架来指导糖尿病预防干预措施设计和开发的三个阶段:(1)总结证据;(2)确定当地实施障碍;(3)衡量绩效。在第一阶段,我们对关联的电子健康记录报销数据进行了回顾性队列分析,以评估糖尿病前期管理的现行做法。在第 2 阶段,我们对 16 名初级保健医生、7 名支付方领导和 31 名患者进行了深入访谈,以了解预防糖尿病的共同障碍和促进因素。在第 3 阶段,我们利用第 1 和第 2 阶段的调查结果,制定了干预措施的核心要素和绩效衡量标准,以评估干预措施的吸收情况:结果:在第 1 阶段(回顾性队列分析),我们发现很少有糖尿病前期患者接受糖尿病预防干预。在第 2 阶段(利益相关者参与),我们发现了一些常见的障碍,包括患者对糖尿病前期缺乏了解,以及临床医生对糖尿病预防计划缺乏了解。在第 3 阶段(干预措施开发),我们开发了 START 糖尿病预防临床路径,作为系统性变革包,以解决第 1 和第 2 阶段中发现的障碍和促进因素、绩效衡量标准以及支持干预措施组成部分的资源工具包:TRiP框架有助于确定糖尿病前期的循证护理实践,并制定出适合的、可操作的干预措施和实施计划,以提高基层医疗机构对糖尿病前期的治疗率。其他医疗系统或诊所可以调整和使用我们的改革方案,以预防糖尿病或其他相关慢性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Quality
BMJ Open Quality Nursing-Leadership and Management
CiteScore
2.20
自引率
0.00%
发文量
226
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信